Companies · Other Health Care

Cardinal Spine, LLC

LOUISVILLE · Other Health Care

Diligence memoA one-page analyst read on Cardinal Spine, LLC — recommendation, valuation, rhythm, risks.
$748K
Total raised · real
1
Rounds
8.3×
Latest step-up
Top 73%
Sector rank · raised
Recurring offerings
Latest stage · inferred · Thu Jun 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Cardinal Spine, LLC has raised $748K over 1 round; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Program ended
  • Last raise 13.0 yr ago; this sector typically re-raises about every 14 months.
  • For a recurring offering issuer, long silence usually means the offering program is inactive or ended; it is not proof the legal entity is defunct.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Recurring offering issuerhigh confidence

Cardinal Spine, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Program-like
Frequent filings and follow-ons read more like a securities offering program than discrete startup rounds.
Lifecycle
13.0 yr record
Peak capital year was 2013 with $13.6M across 27 filings.
Market position
ahead of 28% of Other Health Care peers
Capital scale is ahead of 28% of Other Health Care peers; modeled value is above 51% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • 27 dated financing filings, averaging about 0 months apart.
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2013: $13.6M across 27 filings.
  • Largest single filing was $1.3M on 2013-07-01.
  • Filing rows sum to $13.6M, while canonical raised total is $748K; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Cardinal Spine, LLC is one of 5377 Other Health Care companies tracked from LOUISVILLE. By capital raised it ranks in the long tail (ahead of 28% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 06
Reg D exemption
2008
Year incorporated
Amount raised vs valuation, by year

This issuer has a dense recurring filing history, so the chart groups filings by year. Solid bars are annual reported capital reported; hatched bars show the latest modeled value est. observed in that year. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Annual capital raised · realLatest value in year · estCumulative funded · real

Dense history compressed: 27 filings shown as 1 yearly buckets. Hover a bucket for filing count, annual capital, and latest modeled value.

$0$13M$25M$38M$50M2013: 27 filings Raised $14M total (real) Latest modeled valuation $31M (est)201327 filings

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps

This looks like a recurring offering series, so a VC stage ladder would be misleading. Showing the filed offering sequence instead.

Initial offering$625K · 2013
Follow-on offering$100K · 2013
Follow-on offering$475K · 2013
Follow-on offering$748K · 2013
Follow-on offering$650K · 2013
Follow-on offering$450K · 2013
Follow-on offering$550K · 2013
Follow-on offering$500K · 2013
Follow-on offering$450K · 2013
Follow-on offering$748K · 2013
Follow-on offering$710K · 2013
Follow-on offering$425K · 2013
Follow-on offering$325K · 2013
Follow-on offering$300K · 2013
Follow-on offering$685K · 2013
Follow-on offering$748K · 2013
Follow-on offering$225K · 2013
Follow-on offering$660K · 2013
Follow-on offering$655K · 2013
Follow-on offering$575K · 2013
Follow-on offering$425K · 2013
Follow-on offering$400K · 2013
Follow-on offering$350K · 2013
Follow-on offering$250K · 2013

Showing first 24 of 27 filings to keep the sequence readable.

Modeled valuation trajectory
$23.0M
Base estimate est.
$468K
Conservative case
$261.2M
Upside case
$4.2M
Modeled post-money

This issuer files recurring offerings, so the model treats stage labels as a loose sizing heuristic, not a clean VC ladder. The estimate anchors on reported filing amounts and dates, then applies benchmark dilution, survival, and markup assumptions. Directional, not a quoted figure.

Pre-Seed · modeled $19.3M · 2013-06-272013Pre-Seed · modeled $3.1M · 2013-06-27Pre-Seed · modeled $14.6M · 2013-06-27Pre-Seed · modeled $23.0M · 2013-06-27Pre-Seed · modeled $20.0M · 2013-06-27Pre-Seed · modeled $13.9M · 2013-06-27Pre-Seed · modeled $16.9M · 2013-06-27Pre-Seed · modeled $15.4M · 2013-06-27Pre-Seed · modeled $13.9M · 2013-06-27Pre-Seed · modeled $23.0M · 2013-06-27Pre-Seed · modeled $21.9M · 2013-06-27Pre-Seed · modeled $13.1M · 2013-06-27Pre-Seed · modeled $10.0M · 2013-06-27Pre-Seed · modeled $9.2M · 2013-06-27Pre-Seed · modeled $21.1M · 2013-06-27Pre-Seed · modeled $23.0M · 2013-06-27Pre-Seed · modeled $6.9M · 2013-06-27Pre-Seed · modeled $20.3M · 2013-06-27Pre-Seed · modeled $20.2M · 2013-06-27Pre-Seed · modeled $17.7M · 2013-06-27Pre-Seed · modeled $13.1M · 2013-06-27Pre-Seed · modeled $12.3M · 2013-06-27Pre-Seed · modeled $10.8M · 2013-06-27Pre-Seed · modeled $7.7M · 2013-06-27Pre-Seed · modeled $5.4M · 2013-06-27Pre-Seed · modeled $4.6M · 2013-06-27Seed · modeled $31.0M · 2013-07-012013
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
13.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
13.0 yr
On record since
2013
First round
27
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.3× of median
This company$748K
Sector median$2.4M
Modeled value — vs sector median (estimate, all stages) 1.0× above median
This company$23.0M
Sector median$22.1M

Raised more than 28% of sector peers (real $). Modeled value above 51% of peers (estimate).

Full financing history

This issuer files too frequently for VC stage labels to be meaningful, so rows are shown as initial/follow-on offerings est. instead of Pre-Seed/Seed/Series buckets.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Initial offering$625K2013-06-27$3.5M$19.3M85%
Follow-on offering$100K2013-06-27$556K$3.1M85%
Follow-on offering$475K2013-06-27$2.6M$14.6M85%
Follow-on offering$748K2013-06-27$4.2M$23.0M85%
Follow-on offering$650K2013-06-27$3.6M$20.0M85%
Follow-on offering$450K2013-06-27$2.5M$13.9M85%
Follow-on offering$550K2013-06-27$3.1M$16.9M85%
Follow-on offering$500K2013-06-27$2.8M$15.4M85%
Follow-on offering$450K2013-06-27$2.5M$13.9M85%
Follow-on offering$748K2013-06-27$4.2M$23.0M85%
Follow-on offering$710K2013-06-27$3.9M$21.9M85%
Follow-on offering$425K2013-06-27$2.4M$13.1M85%
Follow-on offering$325K2013-06-27$1.8M$10.0M85%
Follow-on offering$300K2013-06-27$1.7M$9.2M85%
Follow-on offering$685K2013-06-27$3.8M$21.1M85%
Follow-on offering$748K2013-06-27$4.2M$23.0M90%
Follow-on offering$225K2013-06-27$1.3M$6.9M85%
Follow-on offering$660K2013-06-27$3.7M$20.3M85%
Follow-on offering$655K2013-06-27$3.6M$20.2M85%
Follow-on offering$575K2013-06-27$3.2M$17.7M85%
Follow-on offering$425K2013-06-27$2.4M$13.1M85%
Follow-on offering$400K2013-06-27$2.2M$12.3M85%
Follow-on offering$350K2013-06-27$1.9M$10.8M85%
Follow-on offering$250K2013-06-27$1.4M$7.7M85%
Follow-on offering$175K2013-06-27$972K$5.4M85%
Follow-on offering$150K2013-06-27$833K$4.6M85%
Follow-on offering$1.3M2013-07-01$6.3M$31.0M85%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Initial offering$625K2013-06-27
    • First recorded raise — entered as Initial offering.
    • 14 investors on this round.
  2. Follow-on offering$100K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 6.3× smaller than the prior — bridge or down round.
    • Revenue band moved $0–$1M → No revenue.
    • Switched to Rule 06 (was Rule 506(b)).
  3. Follow-on offering$475K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.8× larger than the prior — scaling up.
    • Revenue band moved No revenue → $0–$1M.
    • Switched to Rule 506(b) (was Rule 06).
    • 12 investors on this round.
  4. Follow-on offering$748K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.6× larger than the prior — scaling up.
    • 14 investors on this round.
  5. Follow-on offering$650K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 13 investors on this round.
  6. Follow-on offering$450K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 11 investors on this round.
  7. Follow-on offering$550K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  8. Follow-on offering$500K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 12 investors on this round.
  9. Follow-on offering$450K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 11 investors on this round.
  10. Follow-on offering$748K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× larger than the prior — scaling up.
    • 14 investors on this round.
  11. Follow-on offering$710K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  12. Follow-on offering$425K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 11 investors on this round.
  13. Follow-on offering$325K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 9 investors on this round.
  14. Follow-on offering$300K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  15. Follow-on offering$685K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.3× larger than the prior — scaling up.
    • 13 investors on this round.
  16. Follow-on offering$748K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  17. Follow-on offering$225K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.3× smaller than the prior — bridge or down round.
    • Switched to Rule 06 (was Rule 506(b)).
    • 7 investors on this round.
  18. Follow-on offering$660K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 13 investors on this round.
  19. Follow-on offering$655K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 13 investors on this round.
  20. Follow-on offering$575K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  21. Follow-on offering$425K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 10 investors on this round.
  22. Follow-on offering$400K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 9 investors on this round.
  23. Follow-on offering$350K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 9 investors on this round.
  24. Follow-on offering$250K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  25. Follow-on offering$175K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • Revenue band moved $0–$1M → No revenue.
    • Switched to Rule 06 (was Rule 506(b)).
    • 6 investors on this round.
  26. Follow-on offering$150K2013-06-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  27. Follow-on offering$1.3M2013-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.3× larger than the prior — scaling up.
Intelligence
2013 ~Q3
Modeled next raise · ~0mo cadence
$3.8M
Modeled next size est.range $2.4M$6.0M
8.3×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Frank P. Castro2013-06
Registry & provenance

Cardinal Spine, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1574608
SEC CIK
2008
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Fresenius Medical Care West Frankfort Home, LLCOther Health CarePre-Seed$749K$23.1Msame sector · same stage
MySupport Inc.Other Health CarePre-Seed$746K$19.7Msame sector · same stage
WellTek IncOther Health CarePre-Seed$750K$23.1Msame sector · same stage
Access Genetics LlcOther Health CarePre-Seed$750K$23.1Msame sector · same stage
AVRA Surgical Robotics, Inc.Other Health CarePre-Seed$750K$23.1Msame sector · same stage
Breath of Life LLCOther Health CarePre-Seed$750K$23.1Msame sector · same stage
CareGeneral, LLCOther Health CarePre-Seed$750K$23.1Msame sector · same stage
Caresyntax CorpOther Health CarePre-Seed$750K$23.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Spine Holdings LLCOther Health CareSeries B$851.6M89%
Center for Spine Surgery, LLCOther Health CarePre-Seed$8.4M88%
N H Spine & Ortho, Inc.Other Health CarePre-Seed$22.5M88%
Titan Spine, LLCOther Health CareSeries B$370.5M88%
Spine & Rehab Investors, LLCOther Health CareSeed$11.4M88%
HAPPE Spine, LLCOther Health CareSeries A$10.0M87%
CTQ- Spine, LLCOther Health CarePre-Seed$633K87%
National Spine & Pain Centers Holdings, LLCOther Health CareSeries B$708.9M87%
Frequently asked
How much funding has Cardinal Spine, LLC raised?
Cardinal Spine, LLC has raised approximately $748K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Cardinal Spine, LLC's estimated valuation?
Provath's modeled valuation for Cardinal Spine, LLC is approximately $23.0M (modeled range $468K–$261.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Cardinal Spine, LLC at?
Cardinal Spine, LLC shows a recurring offering pattern rather than a clean VC stage progression. Its most recent recorded round closed around Thu Jun 27.
What does Cardinal Spine, LLC do and where is it based?
Cardinal Spine, LLC operates in the Other Health Care sector, based in LOUISVILLE.
Explore related

See where Cardinal Spine, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Cardinal Spine, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.